-
1
-
-
1642410856
-
Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures
-
COI: 1:STN:280:DC%2BD2c7gs1Whug%3D%3D, PID: 14996343
-
Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat, 2004,11(2):97–107
-
(2004)
J Viral Hepat
, vol.11
, Issue.2
, pp. 97-107
-
-
Lavanchy, D.1
-
2
-
-
79960699693
-
Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size
-
PID: 21617533
-
Luo Z, Xie Y, Deng M, et al. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size. Eur J Gastroenterol Hepatol, 2011,23(8):695–700
-
(2011)
Eur J Gastroenterol Hepatol
, vol.23
, Issue.8
, pp. 695-700
-
-
Luo, Z.1
Xie, Y.2
Deng, M.3
-
3
-
-
84862942769
-
Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures
-
PID: 22041528
-
Tanaka M, Katayama F, Kato H, et al. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol, 2011,21(6):401–416
-
(2011)
J Epidemiol
, vol.21
, Issue.6
, pp. 401-416
-
-
Tanaka, M.1
Katayama, F.2
Kato, H.3
-
4
-
-
24344435917
-
Epidemiology and natural history of hepatitis B
-
PID: 16103976
-
McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis, 2005,25(Suppl 1):3–8
-
(2005)
Semin Liver Dis
, vol.25
, pp. 3-8
-
-
McMahon, B.J.1
-
5
-
-
84862915577
-
Effect and predictive elements for 52 weeks’ telbivudine treatment on naive HBeAg positive chronic hepatitis B
-
PID: 22368682
-
Zhu XF, Lu LX, Wang Y, et al. Effect and predictive elements for 52 weeks’ telbivudine treatment on naive HBeAg positive chronic hepatitis B. Hepat Mon, 2011,11(12):980–985
-
(2011)
Hepat Mon
, vol.11
, Issue.12
, pp. 980-985
-
-
Zhu, X.F.1
Lu, L.X.2
Wang, Y.3
-
6
-
-
84882877800
-
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha
-
COI: 1:CAS:528:DC%2BC3sXhtFKltL7P, PID: 23890815
-
Pollicino T, Bellinghieri L, Restuccia A, et al. Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. Virology. 2013,444(1–2):317–328
-
(2013)
Virology
, vol.444
, Issue.1-2
, pp. 317-328
-
-
Pollicino, T.1
Bellinghieri, L.2
Restuccia, A.3
-
7
-
-
0035189597
-
Chronic hepatitis B
-
COI: 1:STN:280:DC%2BD3MnosV2qtw%3D%3D, PID: 11732013
-
Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology, 2001,34(6):1225–1241
-
(2001)
Hepatology
, vol.34
, Issue.6
, pp. 1225-1241
-
-
Lok, A.S.1
McMahon, B.J.2
-
8
-
-
0036461318
-
Immunology of hepatitis B infection
-
COI: 1:CAS:528:DC%2BD38Xht1Oltbo%3D, PID: 11892495
-
Jung MC, Pape GR. Immunology of hepatitis B infection. Lancet Infect Dis, 2002,2(1):43–50
-
(2002)
Lancet Infect Dis
, vol.2
, Issue.1
, pp. 43-50
-
-
Jung, M.C.1
Pape, G.R.2
-
9
-
-
0036293243
-
Global control of hepatitis B virus infection
-
PID: 12127351
-
Kao JH, Chen DS. Global control of hepatitis B virus infection. Lancet Infect Dis, 2002,2(7):395–403
-
(2002)
Lancet Infect Dis
, vol.2
, Issue.7
, pp. 395-403
-
-
Kao, J.H.1
Chen, D.S.2
-
10
-
-
4644308995
-
Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity
-
Kondo Y, Asabe S, Kobayashi K, et al. Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity. J Med Virol, 2004,4(3):425–433
-
(2004)
J Med Virol
, vol.4
, Issue.3
, pp. 425-433
-
-
Kondo, Y.1
Asabe, S.2
Kobayashi, K.3
-
11
-
-
70350026318
-
HBX-mediated migration of HBV-replicating HepG2 cells: insights on development of hepatocellular carcinoma
-
PID: 19763277
-
Feng H, Zhang J, Li X, et al. HBX-mediated migration of HBV-replicating HepG2 cells: insights on development of hepatocellular carcinoma. J Biomed Biotechnol, 2009, 2009: 930268
-
(2009)
J Biomed Biotechnol
, vol.2009
, pp. 930268
-
-
Feng, H.1
Zhang, J.2
Li, X.3
-
12
-
-
79953315167
-
Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B
-
COI: 1:CAS:528:DC%2BC3MXmslymu7g%3D, PID: 21457439
-
Gane EJ, Wang Y, Liaw YF, et al. Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B. Liver Int, 2011,31(5):676–684
-
(2011)
Liver Int
, vol.31
, Issue.5
, pp. 676-684
-
-
Gane, E.J.1
Wang, Y.2
Liaw, Y.F.3
-
13
-
-
37349120537
-
Telbivudine versus lamivudine in patients with chronic hepatitis B
-
COI: 1:CAS:528:DC%2BD2sXhsVKht7nF, PID: 18094378
-
Lai CL, Gane E, Liaw YF, et al. Telbivudine versus lamivudine in patients with chronic hepatitis B. N Engl J Med, 2007,20;357(25):2576–2588
-
(2007)
N Engl J Med
, vol.357
, Issue.25
, pp. 2576-2588
-
-
Lai, C.L.1
Gane, E.2
Liaw, Y.F.3
-
14
-
-
61849132825
-
On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future
-
COI: 1:CAS:528:DC%2BD1MXktVertbc%3D, PID: 19320233
-
Liaw YF. On-treatment outcome prediction and adjustment during chronic hepatitis B therapy: now and future. Antivir Ther, 2009,14(1):13–22
-
(2009)
Antivir Ther
, vol.14
, Issue.1
, pp. 13-22
-
-
Liaw, Y.F.1
-
15
-
-
0041760773
-
Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy?
-
PID: 12923364
-
Phillips MG, Preedy VR, Hughes RD. Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy? Eur J Gastroenterol Hepatol, 2003,15(9):941–944
-
(2003)
Eur J Gastroenterol Hepatol
, vol.15
, Issue.9
, pp. 941-944
-
-
Phillips, M.G.1
Preedy, V.R.2
Hughes, R.D.3
-
16
-
-
0033849619
-
Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF)
-
COI: 1:STN:280:DC%2BD3cvislylsg%3D%3D, PID: 10960438
-
Cadranel JF, Rufat P, Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology, 2000,32(3):477–481
-
(2000)
Hepatology
, vol.32
, Issue.3
, pp. 477-481
-
-
Cadranel, J.F.1
Rufat, P.2
Degos, F.3
-
17
-
-
0022656928
-
Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver
-
COI: 1:STN:280:DyaL287ksFynsw%3D%3D, PID: 2869260
-
Maharaj B, Maharaj RJ, Leary WP, et al. Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet, 1986,1(8480):523–525
-
(1986)
Lancet
, vol.1
, Issue.8480
, pp. 523-525
-
-
Maharaj, B.1
Maharaj, R.J.2
Leary, W.P.3
-
18
-
-
0020052042
-
Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques—a review
-
COI: 1:STN:280:DyaL383htFKluw%3D%3D, PID: 6211383
-
Nord HJ. Biopsy diagnosis of cirrhosis: blind percutaneous versus guided direct vision techniques—a review. Gastrointest Endosc, 1982,28(2):102–104
-
(1982)
Gastrointest Endosc
, vol.28
, Issue.2
, pp. 102-104
-
-
Nord, H.J.1
-
19
-
-
0022647490
-
Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies
-
COI: 1:STN:280:DyaL287mvFGgsw%3D%3D, PID: 3958472
-
Piccinino F, Sagnelli E, Pasquale G, et al. Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol, 1986,2(2):165–173
-
(1986)
J Hepatol
, vol.2
, Issue.2
, pp. 165-173
-
-
Piccinino, F.1
Sagnelli, E.2
Pasquale, G.3
-
20
-
-
0036793878
-
Prothrombin index decrease: a useful and reliable marker of extensive fibrosis?
-
COI: 1:CAS:528:DC%2BD38XnsVKrtLc%3D, PID: 12362094
-
Cadranel JF, Mathurin P. Prothrombin index decrease: a useful and reliable marker of extensive fibrosis? Eur J Gastroenterol Hepatol, 2002,14(10):1057–1059
-
(2002)
Eur J Gastroenterol Hepatol
, vol.14
, Issue.10
, pp. 1057-1059
-
-
Cadranel, J.F.1
Mathurin, P.2
-
21
-
-
0036793935
-
Prothrombin index is an indirect marker of severe liver fibrosis
-
COI: 1:CAS:528:DC%2BD38XnsVKrtbs%3D, PID: 12362105
-
Croquet V, Vuillemin E, Ternisien C, et al. Prothrombin index is an indirect marker of severe liver fibrosis. Eur J Gastroenterol Hepatol, 2002,14(10):1133–1141
-
(2002)
Eur J Gastroenterol Hepatol
, vol.14
, Issue.10
, pp. 1133-1141
-
-
Croquet, V.1
Vuillemin, E.2
Ternisien, C.3
-
22
-
-
0030830281
-
Noninvasive diagnosis of hepatic fibrosis or cirrhosis
-
COI: 1:CAS:528:DyaK2sXnt1Oqu7k%3D, PID: 9352863
-
Oberti F, Valsesia E, Pilette C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology, 1997,113(5):1609–1616
-
(1997)
Gastroenterology
, vol.113
, Issue.5
, pp. 1609-1616
-
-
Oberti, F.1
Valsesia, E.2
Pilette, C.3
-
23
-
-
0033782827
-
Serum hyaluronan—a non-invasive test for diagnosing liver cirrhosis
-
COI: 1:CAS:528:DC%2BD3cXnvV2ltb0%3D, PID: 11057458
-
Plevris JN, Haydon GH, Simpson KJ, et al. Serum hyaluronan—a non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol, 2000,12(10):1121–1127
-
(2000)
Eur J Gastroenterol Hepatol
, vol.12
, Issue.10
, pp. 1121-1127
-
-
Plevris, J.N.1
Haydon, G.H.2
Simpson, K.J.3
-
24
-
-
0028256364
-
Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C
-
COI: 1:CAS:528:DyaK2cXktVKntLY%3D, PID: 8014451
-
Guechot J, Poupon RE, Giral P, et al. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol, 1994,20(3):388–393
-
(1994)
J Hepatol
, vol.20
, Issue.3
, pp. 388-393
-
-
Guechot, J.1
Poupon, R.E.2
Giral, P.3
-
25
-
-
84887018337
-
The regulation of inflammation by interferons and their STATs
-
PID: 24058799
-
Rauch I, Muller M, Decker T. The regulation of inflammation by interferons and their STATs. JAKSTAT, 2013,2(1):e23820
-
(2013)
JAKSTAT
, vol.2
, Issue.1
, pp. e23820
-
-
Rauch, I.1
Muller, M.2
Decker, T.3
-
26
-
-
68049142973
-
Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C
-
COI: 1:CAS:528:DC%2BD1MXpsFyhsrk%3D, PID: 19596474
-
Bonorino P, Ramzan M, Camous X, et al. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol, 2009,51(3):458–467
-
(2009)
J Hepatol
, vol.51
, Issue.3
, pp. 458-467
-
-
Bonorino, P.1
Ramzan, M.2
Camous, X.3
-
27
-
-
33947411395
-
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage
-
COI: 1:CAS:528:DC%2BD2sXjsVyqsrY%3D, PID: 17353365
-
Dunn C, Brunetto M, Reynolds G, et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med, 2007,204(3):667–680
-
(2007)
J Exp Med
, vol.204
, Issue.3
, pp. 667-680
-
-
Dunn, C.1
Brunetto, M.2
Reynolds, G.3
-
28
-
-
69249113887
-
Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections
-
COI: 1:CAS:528:DC%2BD1MXhtF2is7%2FO, PID: 19470388
-
Oliviero B, Varchetta S, Paudice E, et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology, 2009,137(3):1151–1160, 60 e1-e7
-
(2009)
Gastroenterology
, vol.137
, Issue.3
, pp. 1151-1160
-
-
Oliviero, B.1
Varchetta, S.2
Paudice, E.3
-
29
-
-
78751482977
-
Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients
-
COI: 1:CAS:528:DC%2BC3MXitVeksrY%3D, PID: 21254163
-
Zhang Z, Zhang S, Zou Z, et al. Hypercytolytic activity of hepatic natural killer cells correlates with liver injury in chronic hepatitis B patients. Hepatology, 2011,53(1):73–85
-
(2011)
Hepatology
, vol.53
, Issue.1
, pp. 73-85
-
-
Zhang, Z.1
Zhang, S.2
Zou, Z.3
-
30
-
-
79251563757
-
Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil
-
PID: 21127728
-
Jiang Y, Ma Z, Xin G, et al. Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators Inflamm, 2010,2010: 143026
-
(2010)
Mediators Inflamm
, vol.2010
, pp. 143026
-
-
Jiang, Y.1
Ma, Z.2
Xin, G.3
-
31
-
-
36549070632
-
Therapy of chronic hepatitis B: focus on telbivudine
-
COI: 1:CAS:528:DC%2BD1cXhvF2qt70%3D, PID: 18063258
-
Gaeta GB, Stornaiuolo G. Therapy of chronic hepatitis B: focus on telbivudine. Dig Liver Dis, 2007,39(Suppl 3):S372–S378
-
(2007)
Dig Liver Dis
, vol.39
, pp. S372-S378
-
-
Gaeta, G.B.1
Stornaiuolo, G.2
-
32
-
-
77952576643
-
Innate and adaptive immune responses in hepatitis B virus infection
-
PID: 20460900
-
Das A, Maini MK. Innate and adaptive immune responses in hepatitis B virus infection. Dig Dis, 2010,28(1):126–132
-
(2010)
Dig Dis
, vol.28
, Issue.1
, pp. 126-132
-
-
Das, A.1
Maini, M.K.2
-
33
-
-
84861078273
-
Effects of telbivudine treatment on the circulating CD4(+) T-cell subpopulations in chronic hepatitis B patients
-
PID: 22570512
-
Zheng Y, Huang Z, Chen X, et al. Effects of telbivudine treatment on the circulating CD4(+) T-cell subpopulations in chronic hepatitis B patients. Mediators Inflamm, 2012,2012:789859
-
(2012)
Mediators Inflamm
, vol.2012
, pp. 789859
-
-
Zheng, Y.1
Huang, Z.2
Chen, X.3
-
34
-
-
84861483182
-
Effects of antiviral therapy with telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients
-
COI: 1:CAS:528:DC%2BC38XmtlCqsr4%3D, PID: 21748522
-
Shi TD, Zhang JM, Wang XF, et al. Effects of antiviral therapy with telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients. Clin Exp Med, 2012,12(2):105–113
-
(2012)
Clin Exp Med
, vol.12
, Issue.2
, pp. 105-113
-
-
Shi, T.D.1
Zhang, J.M.2
Wang, X.F.3
-
35
-
-
84868324382
-
Natural killer cells are characterized by the concomitantly increased interferon-gamma and cytotoxicity in acute resolved hepatitis B patients
-
COI: 1:CAS:528:DC%2BC38XhslWjsb%2FK, PID: 23133672
-
Zhao J, Li Y, Jin L, et al. Natural killer cells are characterized by the concomitantly increased interferon-gamma and cytotoxicity in acute resolved hepatitis B patients. PLoS One, 2012,7(11):e49135
-
(2012)
PLoS One
, vol.7
, Issue.11
, pp. e49135
-
-
Zhao, J.1
Li, Y.2
Jin, L.3
-
36
-
-
61449152973
-
Regulatory T cells and viral liver disease
-
PID: 19222744
-
Alatrakchi N, Koziel M. Regulatory T cells and viral liver disease. J Viral Hepat, 2009,16(4):223–229
-
(2009)
J Viral Hepat
, vol.16
, Issue.4
, pp. 223-229
-
-
Alatrakchi, N.1
Koziel, M.2
-
37
-
-
1642453559
-
Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells
-
PID: 14726762
-
Cottrez F, Groux H. Specialization in tolerance: innate CD(4+)CD(25+) versus acquired TR1 and TH3 regulatory T cells. Transplantation, 2004,77(1 Suppl):S12–S15
-
(2004)
Transplantation
, vol.77
, Issue.1
, pp. S12-S15
-
-
Cottrez, F.1
Groux, H.2
-
38
-
-
16244385911
-
Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection
-
COI: 1:CAS:528:DC%2BD2MXjsV2msLs%3D, PID: 15791617
-
Stoop JN, van der Molen RG, Baan CC, et al. Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology, 2005,41(4):771–778
-
(2005)
Hepatology
, vol.41
, Issue.4
, pp. 771-778
-
-
Stoop, J.N.1
van der Molen, R.G.2
Baan, C.C.3
-
39
-
-
84863011093
-
Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B
-
COI: 1:CAS:528:DC%2BC38Xhsl2jurs%3D, PID: 22233255
-
Nan XP, Zhang Y, Yu HT, et al. Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B. Viral Immunol, 2012,25(1):21–8
-
(2012)
Viral Immunol
, vol.25
, Issue.1
, pp. 21-28
-
-
Nan, X.P.1
Zhang, Y.2
Yu, H.T.3
|